106 related articles for article (PubMed ID: 23463483)
1. In non-obese patients, duration of action of rocuronium is directly correlated with body mass index.
Fujimoto M; Tanahira C; Nishi M; Yamamoto T
Can J Anaesth; 2013 Jun; 60(6):552-6. PubMed ID: 23463483
[TBL] [Abstract][Full Text] [Related]
2. Should dosing of rocuronium in obese patients be based on ideal or corrected body weight?
Meyhoff CS; Lund J; Jenstrup MT; Claudius C; Sørensen AM; Viby-Mogensen J; Rasmussen LS
Anesth Analg; 2009 Sep; 109(3):787-92. PubMed ID: 19690247
[TBL] [Abstract][Full Text] [Related]
3. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
[TBL] [Abstract][Full Text] [Related]
4. Neuromuscular blocking effects of rocuronium during desflurane, isoflurane, and sevoflurane anaesthesia.
Wulf H; Ledowski T; Linstedt U; Proppe D; Sitzlack D
Can J Anaesth; 1998 Jun; 45(6):526-32. PubMed ID: 9669005
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effect of rocuronium dosing based on corrected or lean body weight on rapid sequence induction and neuromuscular blockade duration in obese female patients.
Sakızcı-Uyar B; Çelik S; Postacı A; Bayraktar Y; Dikmen B; Özkoçak-Turan I; Saçan O
Saudi Med J; 2016 Jan; 37(1):60-5. PubMed ID: 26739976
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of the dose-response and time course of recovery of atracurium and rocuronium.
Xue F; Zhang Y; Liao X; Liu J; An G
Chin Med J (Engl); 2000 Nov; 113(11):1019-21. PubMed ID: 11776116
[TBL] [Abstract][Full Text] [Related]
7. Rocuronium bromide: time-course of action in underweight, normal weight, overweight and obese patients.
Pühringer FK; Khuenl-Brady KS; Mitterschiffthaler G
Eur J Anaesthesiol Suppl; 1995 Sep; 11():107-10. PubMed ID: 8556996
[TBL] [Abstract][Full Text] [Related]
8. Clinical predictors of duration of action of cisatracurium and rocuronium administered long-term.
Fassbender P; Geldner G; Blobner M; Hofmockel R; Rex C; Gautam S; Malhotra A; Eikermann M
Am J Crit Care; 2009 Sep; 18(5):439-45. PubMed ID: 19723864
[TBL] [Abstract][Full Text] [Related]
9. The pharmacodynamic effects of rocuronium when dosed according to real body weight or ideal body weight in morbidly obese patients.
Leykin Y; Pellis T; Lucca M; Lomangino G; Marzano B; Gullo A
Anesth Analg; 2004 Oct; 99(4):1086-1089. PubMed ID: 15385355
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the duration of neuromuscular blockade following a single bolus dose of rocuronium during laparoscopic gynaecological surgery vs conventional open surgery.
Wang T; Huang S; Geng G
Anaesthesia; 2014 Aug; 69(8):854-9. PubMed ID: 24820378
[TBL] [Abstract][Full Text] [Related]
11. Duration of the action of rocuronium in patients with BMI of less than 25: An observational study.
Takahata O; Takahoko KI; Sasakawa T; Inagaki Y; Takahoko H; Kunisawa T
Eur J Anaesthesiol; 2018 Nov; 35(11):863-866. PubMed ID: 29757926
[TBL] [Abstract][Full Text] [Related]
12. Neuromuscular recovery following rocuronium bromide single dose in infants.
Rapp HJ; Altenmueller CA; Waschke C
Paediatr Anaesth; 2004 Apr; 14(4):329-35. PubMed ID: 15078379
[TBL] [Abstract][Full Text] [Related]
13. Recovery of neuromuscular function after a combination of mivacurium and rocuronium.
Stout RG; Shine TS; Silverman DG; Brull SJ
Yale J Biol Med; 2004 Sep; 77(5-6):149-54. PubMed ID: 15989744
[TBL] [Abstract][Full Text] [Related]
14. Rocuronium 0.3 mg x kg-1 (ED95) induces a normal peak effect but an altered time course of neuromuscular block in patients with Duchenne's muscular dystrophy.
Muenster T; Schmidt J; Wick S; Forst J; Schmitt HJ
Paediatr Anaesth; 2006 Aug; 16(8):840-5. PubMed ID: 16884467
[TBL] [Abstract][Full Text] [Related]
15. Saline Flush After Rocuronium Bolus Reduces Onset Time and Prolongs Duration of Effect: A Randomized Clinical Trial.
Ishigaki S; Masui K; Kazama T
Anesth Analg; 2016 Mar; 122(3):706-711. PubMed ID: 26599796
[TBL] [Abstract][Full Text] [Related]
16. Effect of lung-protective ventilation-induced respiratory acidosis on the duration of neuromuscular blockade by rocuronium.
Taguchi S; Ono K; Hidaka H; Koyama Y
J Anesth; 2016 Dec; 30(6):994-998. PubMed ID: 27562409
[TBL] [Abstract][Full Text] [Related]
17. Infusion requirements and reversibility of rocuronium at the corrugator supercilii and adductor pollicis muscles.
Suzuki T; Mizutani H; Miyake E; Fukano N; Saeki S; Ogawa S
Acta Anaesthesiol Scand; 2009 Nov; 53(10):1336-40. PubMed ID: 19650798
[TBL] [Abstract][Full Text] [Related]
18. Intubating conditions and neuromuscular block after divided dose mivacurium or single dose rocuronium.
Patel N; Kamath N; Smith CE; Pinchak AC; Hagen JH
Can J Anaesth; 1997 Jan; 44(1):49-53. PubMed ID: 8988824
[TBL] [Abstract][Full Text] [Related]
19. The effect of time of day on the duration of neuromuscular blockade elicited by rocuronium.
Cheeseman JF; Merry AF; Pawley MD; de Souza RL; Warman GR
Anaesthesia; 2007 Nov; 62(11):1114-20. PubMed ID: 17924891
[TBL] [Abstract][Full Text] [Related]
20. The effect of desflurane on rocuronium onset, clinical duration and maintenance requirements.
Stout RG; Gan TJ; Glass PS; Silverman DG; Brull SJ
Acta Anaesthesiol Belg; 2006; 57(4):349-53. PubMed ID: 17236635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
